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Maternal Smoking During Pregnancy and
Offspring Health Outcomes: The Role of
Epigenetic Research in Informing Legal Policy
and Practice
Taylor F. Smith,* Matthew A. Maccani,** and Valerie S. Knopik***
Scientific advances in epidemiology and epigenetics emphasize the importance of
prenatal and intergenerational environmental influences and epigenetic regulation in
altering vulnerability for later health outcomes. These findings may have wide-ranging
legal implications; however, to avoid misapplication, a thorough understanding of the
scientific literature and legal precedent is warranted. A growing body of literature
suggests that negative health outcomes associated with prenatal smoke exposure may
result, in part, from aberrant epigenetic regulation of gene expression. Such findings
emphasize the need to reduce rates of prenatal cigarette smoke exposure in order to
promote health for both current and future generations. This Article provides a focused
overview of research examining the interrelationships between maternal smoking
during pregnancy, epigenetic regulation, and vulnerability for later health outcomes.
Additionally, this Article discusses legal, ethical, and policy challenges related to
reducing smoke exposure during pregnancy.
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Introduction
One’s prenatal environment, and in some cases the prenatal
environment of one’s ancestors, may contribute to the development of
cardiovascular disease, type 2 diabetes, obesity, cancer, and
1
neurodevelopmental disorders. Recent advances in epidemiological
2
3
theory and epigenetics have led to a major paradigm shift in research
investigating the causes of later health and behavior. These advances
provide a useful framework and novel tools to help examine how early
environmental influences impact vulnerability for later health outcomes.
4
5
Many of society’s most costly, impairing, and deadly diseases have
6
early developmental origins. From a public health perspective, these
findings hold great promise as preventative interventions may aim to
reduce exposure to adverse environmental influences. Furthermore, there
has been increased interest in understanding the processes linking early
environments—even those from previous generations—to later health
outcomes. Epigenetic mechanisms may provide a bridge for how the
environment gets “under the skin” and impacts biological vulnerability to
future diseases and complications. Future health interventions may also
7
target modifiable epigenetic mechanisms.
In addition to public health implications, the role of early
environmental influences and related epigenetic mechanisms on later
health challenges may have wide-ranging implications for legal policy
and practice. A growing body of literature suggests that negative health
outcomes associated with prenatal smoke exposure may result partially
from aberrant epigenetic regulation of gene expression. Furthermore,
intergenerational epigenetic effects may transmit the adverse effects of

1. See Tessa Roseboom et al., The Dutch Famine and its Long-Term Consequences for Adult
Health, 82 Early Hum. Dev. 485, 486 (2006).
2. Epidemiological theory, such as the “developmental origins of health and disease” hypothesis,
provides a framework for understanding the causes and patterns of disease. See generally Peter D.
Gluckman & Mark A. Hanson, Living with the Past: Evolution, Development, and Patterns of Disease,
305 Science 1733 (2004).
3. Epigenetics researches changes in gene expression that are not caused by changes in the
sequence of DNA. See generally Adrian Bird, Perceptions of Epigenetics, 447 Nature 396 (2007).
4. See generally Benjamin G. Druss et al., The Most Expensive Medical Conditions In America,
21 Health Aff., no. 4, 2002, at 105.
5. See Arialdi M. Minino & Betty L. Smith, Ctrs. for Disease Control & Prevention, 49
National Vital Statistics Reports 12, at 2–4 (Oct. 2001) (discussing the leading causes of death from
1999–2000, including diseases).
6. See generally Robert Barouki et al., Developmental Origins of Non-Communicable Disease:
Implications for Research and Public Health, Environmental Health (Jun. 27, 2012, 11:42 AM),
http://www.ehjournal.net/content/11/1/42.
7. See infra Part I.B.3.
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cigarette smoke exposure from one generation to the next. If aberrant
epigenetic effects are found to link environmental exposure with negative
health outcomes, then epigenetic evidence may be considered when
determining criminal culpability or negligence of the “bad actor” who has
exposed others to cigarette smoke. In addition, given that smokingassociated negative health outcomes may be realized in subsequent
generations through epigenetic transmission, problems may also arise in
applying statutes of limitation to such cases. Consider these examples of
potential cases:
If a grandmother smoked during her pregnancy with a daughter,
should that grandmother be held responsible for smoking-associated
diseases and symptoms present in her grandchild—even if that
grandchild’s only exposure to cigarette smoke resulted from her mother’s
prenatal exposure to smoke?
The literature on the potential hazards of passive (or “secondhand”)
smoke has grown substantially. Due to this growing awareness, might a
father who smoked near a pregnant woman be held liable for negative
smoking-related health consequences that result from the many chemicals
now known to be present in secondhand smoke? Given that even small
doses of harmful exposures can lead to deleterious effects, what level of
cigarette smoke exposure would be considered prosecutable?
This Article highlights the potential ethical, legal, and policy issues
stemming from research on the developmental origins of later health
outcomes. Part I provides background and an overview of the
Developmental Origins of Health and Disease model, with an emphasis on
fetal programming. Part II discusses epigenetic concepts within the context
of environmental epigenetics and reviews the impact of smoke exposure in
utero on epigenetic processes and health outcomes. The Article concludes,
in Part III, with a discussion of ethical, legal, and policy implications of the
interpretation and application of epigenetic findings.

I. Fetal Origins of Later Health Outcomes
A. Barker’s Hypothesis and the Dutch Famine of 1944–1945
Multiple epidemiological studies have observed that populations
exposed to a limited nutrient supply in utero and who experienced
9
restricted fetal growth are at greater risk for diseases later in life. Barker’s
Hypothesis, which stems from these observations, states that fetal

8. See generally Dawn P. Misra et al., Maternal Smoking and Birth Weight: Interaction with
Parity and Mother’s Own In Utero Exposure to Smoking, 16 Epidemiology 288 (2005).
9. See, e.g., D.J.P. Barker, The Origins of the Developmental Origins Theory, 261 J. Internal
Med. 412 (2007); Pathik D. Wadhwa et al., Developmental Origins of Health and Disease: Brief History of
the Approach and Current Focus on Epigenetic Mechanisms, 27 Seminars Reprod. Med. 358 (2009).
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undernourishment leads to lasting alterations in the structure and function
10
of organs and subsequent increased vulnerability for adult disease. In
11
particular, the Dutch Famine Birth Cohort study has offered key, but
tragic, insights into the association of fetal malnutrition with later health.
In support of the Allied Forces’ momentum during World War II,
the exiled Dutch government called for a strike of the national
12
railroads. In response, the German administration placed a food
transport embargo on the western Netherlands, which was still under
13
German control. The embargo was altered in November 1944 to allow
food transport by water, but due to an early and harsh winter, this form of
14
transport was not feasible. The embargo and harsh winter led to famine
in the western Netherlands, and as a result, adult daily rations dropped to
between 400–800 calories from December 1944 to April 1945, and
supplementary calories for women who were pregnant or nursing were
15
no longer available.
The Dutch Famine (or Hunger Winter) was associated with
significant morbidity and mortality. The link between in utero
environment and later health outcomes was illuminated by historical
circumstances such as the circumscribed period of the famine, detailed
records of daily rations and health outcomes and limited supply of
supplemental food. The Dutch Famine Birth Cohort Study followed
individuals who were exposed to the famine prenatally and assessed
associations of prenatal malnutrition with later health outcomes. Results
from this study demonstrated that fetal malnutrition was associated with
increased
risk
for
various
non-communicable
health
and
16
neurodevelopmental problems including cardiovascular disease, type 2
17
18
19
20
diabetes, cancer, obesity, and schizophrenia. The relationship
between fetal malnutrition and later health outcomes also depended on
21
the gestational timing of famine. These findings emphasize the critical
importance of environmental influences during prenatal development and

10. Barker, supra note 9, at 412.
11. Roseboom et al., Effects of Prenatal Exposure to the Dutch Famine on Adult Disease in Later
Life: An Overview, 185 Molecular & Cellular Endocrinology 93 (2001).
12. Id. at 94.
13. Id.
14. Id.
15. Id.
16. Rosenbloom et al., supra note 1, at 489.
17. Id. at 487–88.
18. Id. at 489.
19. See generally Gian-Paolo Ravelli et al., Obesity in Young Men After Famine Exposure In
Utero and Early Infancy, 295 New Eng. J. Med. 349 (1976).
20. See generally E.S. Susser & S.P. Lin, Schizophrenia After Prenatal Exposure to the Dutch
Hunger Winter of 1944–1945, 49 Archives Gen. Psychiatry 983 (1992).
21. Rosenbloom et al., supra note 1, at 488.
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that vulnerability for a specified health outcome may relate to both the
timing and nature of prenatal environmental exposures.
B. The Developmental Origins of Health and Disease Hypothesis
Findings from the Dutch Famine Birth Cohort study emphasize the
critical importance of the prenatal period in the programming of multiple
developmental systems. Other studies of humans and animals have
broadened our understanding of adverse prenatal environmental
influences and their relationship to later health outcomes. Such studies
have shown, for example, that exposure to toxicants (such as cigarette
smoke), maternal illnesses (such as influenza or depression), medications
(such as antidepressants), fetal hypoxia, and other pregnancy
22
complications have an adverse impact on later health. To account for
these findings, Barker’s hypothesis was expanded to the Developmental
23
Origins of Health and Disease hypothesis (“DOHaD”).
DOHaD provides a comprehensive framework to conceptualize
how the interplay of genetic and early environmental factors can cause
vulnerability for later health, behavior, and disease. DOHaD
hypothesizes that prenatal environmental influences contribute to the
programming of the fetus and, in a way, attempt to impart a maternal
24
forecast on the developing fetus. The theory of “fetal programming”
postulates that a large milieu of exposures comprise the prenatal
environment, including nutrients, drugs, trauma, and stress. A prenatal
environment comprised mostly of healthy exposures and proper nutrition
and devoid of negative exposures is theorized to result in the mother
imparting a rich maternal forecast on her fetus—a prediction that the
postnatal environment will be one in which resources are plentiful and
25
harmful negative exposures are minimal. On the contrary, a largely
adverse prenatal environment (one comprised of a number of negative
exposures and mostly devoid of positive environmental influences) is
theorized to result in a mother imparting a poor maternal forecast on her
26
fetus, which is often characterized by restricted fetal growth. This
negative maternal forecast predicts that the postnatal environment will
be one in which positive resources and exposures are scarce while
22. See, e.g., K. Latimer et al., Disruptive Behaviour Disorders: A Systematic Review of Environmental
Antenatal and Early Years Risk Factors, 38 Child: Care, Health & Dev. 609, 611–28 (2012).
23. See generally Gluckman & Hanson, supra note 2.
24. Valerie S. Knopik et al., The Epigenetics of Maternal Cigarette Smoking During Pregnancy
and Effects on Child Development, 24 Dev. & Psychopathology 1377, 1379 (2012).
25. Id.
26. See generally C.N. Hales & D.J.P. Barker, Type 2 (Non-Insulin-Dependent) Diabetes Mellitus: the
Thrifty Phenotype Hypothesis, 35 Diabetologia 595 (1992). According to Hales and Barker the “thrifty
phenotype” describes the notion that fetal malnutrition is associated with restricted fetal growth and
lasting changes in glucose-insulin metabolism which increases vulnerability for metabolic problems,
including type 2 diabetes, when exposed to a nutrient rich postnatal environment. See generally id.
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negative exposures are abundant. Moreover, maternal forecasts that are
discordant with the post-birth environment—that incorrectly predict the
post-birth environment—have been hypothesized to be associated with a
number of negative consequences for the child later in life, such as an
increased risk for cardiovascular and metabolic diseases. This outcome
was observed in many of the children exposed to in utero famine during
the Dutch Hunger Winter, who were imparted with negative maternal
forecasts and were born growth-restricted but who experienced a post27
birth environment that was abundant with resources.
Increased vulnerability for poor health outcomes may result from
multiple developmental processes including, but not limited to, predictive
adaptive responses, developmental delays, or developmental disruptions.
Predictive adaptive responses describe an organism’s prenatal structural
and functional adaptations to promote survival in a similar postnatal
28
environment. Vulnerability for poor health outcomes may then arise
from a mismatch between the prenatal and postnatal environment. This
mismatch confers vulnerability for disease as the organism is functioning in
an environment for which it did not prepare. As a result, the fetus may be
ill-equipped to function adaptively in the postnatal environment. For
example, in response to a decreased placental-fetal blood flow, a fetus may
preferentially direct blood flow and nutrients to the brain, known as the
29
“brain-sparing effect.” Although this may promote neurovascular
functioning in a nutrient poor environment, it may also constrain cerebral
30
vascular plasticity later in life.
In addition, brain-sparing blood flow does not completely protect
31
against later behavioral problems as the nutrient and oxygen availability
is more abundant in the postnatal environment. Prenatal environmental
influences may also cause vulnerability for later health problems by
disrupting developmental processes. For example, exposure to teratogens,
32
may disrupt
including several compounds in cigarette smoke,
developmental processes without any forecasted or actual adaptive
advantage. Although prenatal environmental influences may directly
27. See Knopik, supra note 24, at 1379; see also David J.P. Barker & Phillipa M. Clark, Fetal
Undernutrition and Disease in Later Life, 2 Revs. Reprod. 105, 109 (1997); Susanne R. de Rooij et al.,
Prenatal Undernutrition and Cognitive Function in Late Adulthood, 107 Proceedings Nat’l Acad. Sci.
U.S. 16881, 16883 (2010).
28. See generally Gluckman & Hanson, supra note 2. Predictive adapted responses describe the
process of fetal programming in response to the prenatal milieu. Id.
29. Ahmet A. Baschat, Fetal Responses to Placental Insufficiency: An Update, 111 BJOG: Int’l J.
Obstetrics & Gynaecology 1031, 1035 (2004).
30. Jing Fu & Per Olofsson, Restrained Cerebral Hyperperfusion in Response to Superimposed
Acute Hypoxemia in Growth-Restricted Human Fetuses with Established Brain-Sparing Blood Flow,
82 Early Hum. Dev. 211, 215 (2006).
31. Sabine J. Roza et al., What Is Spared by Fetal Brain-Sparing? Fetal Circulatory Redistribution
and Behavioral Problems in the General Population, 168 Am. J. Epidemiology 1145, 1145 (2008).
32. See generally Knopik, supra note 24.
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impact vulnerability for later health outcomes, it is important to consider
indirect effects and the role of other factors. Among individuals exposed to
adverse prenatal environmental influences, vulnerability for later health
outcomes may then be moderated by the postnatal environment and
genetic effects.
1. Postnatal Environmental Influences
The postnatal environment continues to impact vulnerability for
health outcomes throughout life. For example, rat pups that are exposed
to low levels of maternal nurturing behavior (such as licking, grooming,
and arched back nursing) exhibit increased fearful behavior and
hypothalamic-pituitary-adrenal axis response to stress compared to pups
33
exposed to high levels of maternal nurturing behavior. This postnatal
environmental effect is believed to be mediated, in part, by differences in
DNA methylation of the glucocorticoid receptor gene in the
hippocampus—an epigenetic mechanism described in detail in
34
Part I.B.3. Although preliminary, findings in studies of humans suggest
that maternal nurturing behavior like infant stroking may produce
35
The mechanism underlying this
similar behavioral outcomes.
relationship in humans has not yet been fully examined but these
findings demonstrate that postnatal environmental experiences may also
impact vulnerability for later health outcomes.
2. Intergenerational Transmission of Environmental Effects
Environmental influences may also impact health outcomes in
subsequent generations. For example, prenatal cigarette smoke exposure
may put offspring at risk for poor health outcomes (such as low birth
weight) and this relationship has been shown to be exacerbated in
mothers who themselves were exposed to maternal smoking during their
36
own fetal development. These findings suggest that environmental
exposures may have a multi-generational impact on health outcomes,
which emphasizes the public health significance of limiting exposure to
37
adverse environmental factors.

33. Ian C.G. Weaver et al., Epigenetic Programming by Maternal Behavior, 7 Nature
Neuroscience 847, 847 (2004).
34. Id.
35. Helen Sharp et al., Frequency of Infant Stroking Reported by Mothers Moderates the Effect of
Prenatal Depression on Infant Behavioural and Physiological Outcomes, PLoS One, Oct. 2012, at 1, 8.
36. Misra, supra note 8, at 291–92.
37. Peter D. Gluckman et al., Developmental Origins of Health and Disease: Reducing the Burden
of Chronic Disease in the Next Generation, Genome Med. (Feb. 24, 2010, 2:14 PM),
http://www.genomemedicine.com/content/2/2/14.
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3. Genetic Influences
Most health and behavioral outcomes are multifactorial in nature,
which means that across individuals, an outcome of interest (such as
antisocial behavior) is influenced by many different genes and many
different environmental factors. This does not, however, preclude the
possibility that some individuals may have a much simpler etiology (such
as rare genetic variation). Before describing the role of epigenetic effects
within DOHaD, it is first necessary to provide a brief overview of how
genetic variation is associated with health outcomes.
a. Direct Genetic Effects
Variation in DNA sequence or chromosomal abnormalities may
directly influence vulnerability for later health outcomes. For example,
although environmental factors account for the majority of variability in
38
39
fetal growth, genetic effects play a substantial role. This example
highlights the importance of considering the impact of both genetic and
environmental influences factors on fetal growth (used by many research
groups as a proxy measure for the quality of the in utero environment) and
40
later health outcomes.
b. Gene-Environment Correlation
Although exposure to other risk factors, such as cigarette smoke, are
categorized as environmental in nature, most environmental risk factors
41
are correlated with genetic influences. Gene-environment correlation
42
takes multiple forms, and passive gene-environment correlation may be
most influential during fetal development. Passive gene-environment
correlation occurs when the child’s genotype, which is inherited from
43
parents, is associated with the environment in which the child is raised.
For example, mothers may have a genetic liability to engage in risky
behavior and pass down this genetic liability to their offspring. However,
having a genetic liability for risky behavior also makes it more likely that
the developing fetus is exposed to adverse prenatal exposures that are

38. Christina M. Hultman et al., Birth Weight and Attention-Deficit/Hyperactivity Symptoms in
Childhood and Early Adolescence: A Prospective Swedish Twin Study, 46 J. Am. Acad. Child &
Adolescent Psychiatry 370, 375 (2007).
39. Id.; D.O. Mook-Kanamori, Heritability Estimates of Body Size in Fetal Life and Early
Childhood, PLoS One, July 2013, at 3–7.
40. See generally Valerie S. Knopik, Maternal Smoking During Pregnancy and Child Outcomes:
Real or Spurious Effect?, 34 Developmental Neuropsychology 1 (2009).
41. See generally Kenneth S. Kendler & Jessica H. Baker, Genetic Influences on Measures of the
Environment: A Systematic Review, 37 Psychol. Med. 615 (2007).
42. Sara R. Jaffee & Thomas S. Price, The Implications of Genotype–Environment Correlation for
Establishing Causal Processes in Psychopathology, 24 Dev. & Psychopathology 1253, 1253–54 (2012).
43. Id. at 1253.
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associated with maternal risky behavior, such smoking cigarettes. Thus, it
is important to disentangle the effects of a genetic liability for risky
behavior and smoke exposure on later health outcomes by using
genetically-informed designs. For example, comparing siblings with the
same mother who were differentially exposed to prenatal smoking parses
out a genetic liability for risky behavior from maternal smoking during
44
pregnancy. This genetically informed design would allow for a more
focused investigation of the effect that maternal smoking during
45
pregnancy has on later health outcomes.
c.

Gene-Environment Interaction

Gene-environment interaction occurs when the relationship between
an environmental factor and a later health outcome depends on the
46
individual’s or parent’s genotype. Great interest in identifying the role of
gene-environment interactions has been fueled by their potential to
47
elucidate processes that underlie health outcomes. Gene-environment
interaction may provide insight into how environmental factors impact
biological vulnerability for later outcomes, but the exact mechanisms
underlying these effects are often unknown. Thus, the application of gene48
environment interactions to medical and legal fields is frequently limited
by a lack of understanding of the biological mechanisms underlying these
effects. Environmentally induced epigenetic modifications may represent
the most promising biological mechanisms underlying gene-environment
49
interactions.

II. Epigenetics of Maternal Smoking During Pregnancy
A. Epigenetic Mechanisms
“There are few situations during the life course where . . . gene–
environment interactions[] are more striking than during prenatal
50
development.” There has been research to better understand the causes

44. Knopik, supra note 40, at 18.
45. Id.
46. Terrie E. Moffitt et al., Strategy for Investigating Interactions Between Measured Genes and
Measured Environments, 62 Archives Gen. Psychiatry 473, 473 (2005).
47. Id.
48. William Bernet et al., Bad Nature, Bad Nurture, & Testimony Regarding MAOA & SLC6A4
Genotyping at Murder Trials, 52 J. Forensic Sci. 1362, 1362 (2007).
49. See generally R.C. Bagot & M.J. Meaney, Epigenetics & the Biological Basis of Gene ×
Environment Interactions, 49 J. Am. Acad. Child & Adolescent Psychiatry 752 (2010).
50. Knopik et al., supra note 24, at 1377; see Matthew A. Maccani & Carmen J. Marsit, Epigenetics in
the Placenta, 62 Am. J. Reprod. Immunology 78, 78 (2009) (“There are only a few settings where the
importance of this gene-environment interface is more profound than during intrauterine development,
where the ‘critical windows’ are narrower and where disruption or modification can influence fetal
development as well as lead to programming of health throughout the life course.”).
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and effects of DOHaD, including investigation into the molecular
mechanisms of fetal programming with a special focus placed on
51
epigenetics.
Epigenetics is the study of changes in gene expression, or whether a
gene is turned on or off, that are not caused by changes in the sequence of
52
DNA. Recent research has suggested that epigenetic mechanisms may be
the conduit through which environmental factors, like “stress, prenatal
nutrition, or prenatal drug exposure can lead to changes in gene expression
from one cell to its daughter cells and, in some cases, from one generation
53
to the next.” From such analyses, it has been hypothesized that
epigenetics may be one mechanism through which fetal programming can
54
occur. Research has discovered four main modes of epigenetic gene
55
56
DNA methylation,
noncoding RNA-mediated gene
regulation:
57
58
regulation (especially by microRNA (“miRNA”)), imprinting, and
59
histone modification.

51. See Maccani & Marsit, supra note 50, at 78.
52. Bird, supra note 3, at 396.
53. Knopik, supra note 40, at 1380. See generally Wadhwa, supra note 9, James M. Swanson et al.,
Developmental Origins of Health & Disease: Environmental Exposures, 27 Seminars in Reprod. Med. 391
(2009).
54. See generally Bagot & Meaney, supra note 49.
55. For an extensive description of these epigenetic mechanisms, as well the technological
advances that have made it possible to measure changes to these modes of epigenetic regulation which
can result in changes to gene expression, see generally Maccani & Marsit, supra note 50.
56. DNA methylation is the most widely studied mode of epigenetic gene regulation. In brief,
DNA methylation involves the attachment of methyl group (an organic compound) to cytosine (one of
the four main bases of DNA) in cytosine/guanine-rich regions of DNA. A general rule—one that is
usually, but not always, true—is that when cytosines in the promoter region of a gene are methylated,
that gene will be effectively silenced by methylation (i.e., the gene would be turned “off”). Conversely,
when a given stretch of cytosines in the promoter region of a gene are not methylated, that gene will
not be silenced by methylation (i.e., the gene would remain turned “on”). Research suggests that it is
not the methylation of DNA itself that contributes most to the shutting off of gene expression but
rather the altered binding of various proteins to methylated stretches of DNA which leads to
dysregulation of expression of genes. The removal and resetting of methylation patterns during
embryonic development make the prenatal period an especially critical window during which the
environment can have major effects on the offspring. See generally Maccani & Marsit, supra note 50;
Matthew A. Maccani & Valerie S. Knopik, Cigarette Smoke Exposure-Associated Alterations to NonCoding RNA, Frontiers Genetics, Apr. 2012, at 1.
57. Ever since early discoveries of RNA as a product of the transcription of DNA, many have
theorized that RNA may not only act as the intermediate step on the pathway from DNA to protein
but may also have a degree of regulatory activity itself. Of the types of non coding RNA (“ncRNA”)
involved in epigenetic gene regulation, the three best-characterized forms are microRNA (“miRNA”),
Piwi-interacting RNA (“piRNA”), and long non-coding RNA (“long ncRNA”), with miRNA getting
the most research attention to date. miRNA have been discovered in a variety of species and have
been shown to be important regulators of a number of biological processes, including development,
cell cycle regulation, and even cancer progression. miRNA function to regulate gene expression posttranscriptionally by base pairing to a target mRNA sequence. The specific mechanism of miRNAmediated gene regulation appears to be dependent on a number of factors, the most important of
which appears to be the degree of complementarity between the miRNA sequence and the target
mRNA sequence. See generally Mariana Lagos-Quintana et al., Identification of Novel Genes Coding
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for Small Expressed RNAs, 294 Science 853 (2001). As a general rule, perfect complementarity of a
miRNA to its target mRNA sequence will result in the degradation of the mRNA transcript by a
mechanism of Argonaute-catalyzed mRNA cleavage. See generally Gyorgy Hutvagner & Phillip D.
Zamore, A microRNA in a Multiple-Turnover RNAi Enzyme Complex, 297 Science 2056 (2002); JiJoon Song et al., Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity,
305 Science 1434 (2004); Soraya Yekta et al., MicroRNA-Directed Cleavage of HOXB8 mRNA,
304 Science 594 (2004). Imperfect sequence complementarity between a miRNA and its target mRNA
will result in the translational repression of the target mRNA by blocking or altering the function of
translational machinery through mechanisms, including the inhibition of translation initiation and
poly(A) shortening. See generally Witold Filipowicz et al., Mechanisms of Post-Transcriptional
Regulation by microRNAs: Are the Answers in Sight?, 9 Nature Revs. Genetics 102 (2008); LagosQuintana et al., supra note 57. Due to the fact that partial or imperfect complementarity of a miRNA
to a target mRNA can lead to translational repression which can effectively silence a gene, a single
miRNA has been observed and speculated to have the capability of regulating a large number of
genes. See Tingting Du & Phillip D. Zamore, Beginning to Understand microRNA Function, 17 Cell
Res. 661 (2007). Some research has also pointed to the possibility that miRNA can utilize a
combination of both translational repression and mRNA degradation as the mechanism for their posttranscriptional gene regulation, but more work is ongoing to more definitively characterize the
mechanisms of miRNA-mediated regulation of gene expression. See generally Lee P. Lim et al.,
Microarray Analysis Shows That Some microRNAs Downregulate Large Numbers of Target mRNAs,
433 Nature 769 (2005); Maccani & Marsit, supra note 50; Matthew A. Maccani & Carmen J. Marsit,
Exposure and Fetal Growth-Associated miRNA Alterations in the Human Placenta, 2 Clinical
Epigenetics 401 (2011); Maccani & Knopik, supra note 56.
58. Genomic imprinting is the parent-of-origin, allele-specific expression of genes. Imprinted
genes are theorized to be controlled by both non-coding RNAs and changes in DNA methylation at
sites in differentially methylated regions (“DMRs”). During imprinting, DNA methylation functions
to alter the binding of specific transcription factor or enhancer elements (or both) that control the
allele specific expression of the region. See generally Miguel Constancia et al., Imprinting Mechanisms,
8 Genome Res. 881 (1998); Maccani & Marsit, supra note 50; Andrew J. Wood & Rebecca J. Oakey,
Genomic Imprinting in Mammals: Emerging Themes and Established Theories, 2 PLoS Genetics 1677
(2006). Imprinting has been hypothesized to be one of the mechanisms involved in the “parent
conflict” theory. The “parent conflict theory” notes that paternally-expressed genes strongly promote
the utilization of maternal resources to benefit offspring while maternally-expressed genes strongly
promote the preservation of such maternal resources; thus, these parental influences are in direct
conflict with one another. Using such logic, one might conclude that paternally-expressed (and
maternally-imprinted) gene expression attempts to foster the growth of offspring while maternallyexpressed (and paternally-imprinted) gene expression tries to ensure that each offspring has
approximately the same access to maternal resources as its siblings. See generally C. Badcock & B.
Crespi, Imbalanced Genomic Imprinting in Brain Development: An Evolutionary Basis for the
Aetiology of Autism, 19 J. Evolutionary Biology 1007 (2006); Shirley M. Tilghman, The Sins of the
Fathers and Mothers: Genomic Imprinting in Mammalian Development, 96 Cell 185 (1999). Genes
regulated by imprinting are involved in a number of processes including embryonic and placental
development and later-in-life functions such as behaviors and metabolism. Aberrant imprinting
patterns have been described to lead to well-characterized syndromes (including Praeder-Willi and
Angelman Syndromes), altered establishment of imprinted genes (particularly at chromosome 11p15),
and Beckwith-Wiedemann Syndrome, which has also been linked to the use of assisted reproductive
technologies. See generally Aimee S. Chang et al., Association Between Beckwith-Wiedemann
Syndrome and Assisted Reproductive Technology: A Case Series of 19 Patients, 83 Fertility &
Sterility 349 (2005); Michael R. DeBaun et al., Association of In Vitro Fertilization with BeckwithWiedemann Syndrome and Epigenetic Alterations of LIT1 and H19, 72 Am. J. Hum. Genetics 156
(2003); Anthony R. Isles & Anthony J. Holland, Imprinted Genes and Mother-Offspring Interactions,
81 Early Hum. Dev. 73 (2005); E.R. Maher et al., Beckwith-Wiedemann Syndrome and Assisted
Reproduction Technology (ART), 40 J. Med. Genetics 62 (2003); Benjamin Tycko & Ian M. Morison,
Physiological Functions of Imprinted Genes, 192 J. Cell Physiology 245 (2002).
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B. Environmental Epigenetics
Epigenetic mechanisms have been investigated in a variety of settings.
The subfield of “environmental epigenetics” studies how environmental
60
exposures may affect epigenetic mechanisms. A special focus of
“environmental epigenetics” research has been to determine how
environmental exposures during critical windows and sensitive periods of
development, such as during pregnancy, might influence epigenetics and
61
therefore affect the developing fetus and fetal programming. Research in
both human cohorts and model systems (such as animals) continues to
characterize the influence of environmental exposures on epigenetics.
Prenatal exposures may, both directly and indirectly, influence fetal
programming through epigenetic mechanisms. In addition, these
epigenetic mechanisms, such as DNA methylation profiles or miRNA

59. Histone modifications involve the acetylation, methylation, phosphorylation, and
ubiquitination of histone proteins around which DNA is wrapped, leading to regulation of gene
expression. See generally Atsushi P. Kimura et al., Epigenetic Modifications at the Human Growth
Hormone Locus Predict Distinct Roles for Histone Acetylation and Methylation in Placental Gene
Activation, 18 Molecular Endocrinology 1018 (2004); Bryan M. Turner, Cellular Memory and the
Histone Code, 111 Cell 285 (2002). Such modifications of the amino-terminal tails of core histones by
acetylation, phosphorylation, and methylation can determine gene activity by altering the accessibility
of DNA to factors which can lead to (or repress) gene expression. See Thomas Jenuwein & C.D. Allis,
Translating the Histone Code, 293 Science 1074 (2001); Brian D. Strahl & C.D. Allis, The Language of
Covalent Histone Modifications, 403 Nature 41 (2000); Yi Zhang & Danny Reinberg, Transcription
Regulation by Histone Methylation: Interplay Between Different Covalent Modifications of the Core
Histone Tails, 15 Genes & Dev. 2343 (2001). Histone methyltransferases—enzymes which aid in the
transfer of methyl groups to histones—have been identified and characterized, including the H3-K4
methyltransferase and five H3-K9 methyltransferases. See generally Kenichi Nishioka et al., Set9,
a Novel Histone H3 Methyltransferase that Facilitates Transcription by Precluding Histone Tail
Modifications Required for Heterochromatin Formation, 16 Genes & Dev. 479 (2002); Hidesato Ogawa
et al., A Complex with Chromatin Modifiers that Occupies E2F- and Myc-Responsive Genes in G0
Cells, 296 Science 1132 (2002); Stephen Rea et al., Regulation of Chromatin Structure by Site-Specific
Histone H3 Methyltransferases, 406 Nature 593 (2000); David C. Schultz et al., SETDB1: A Novel
KAP-1-Associated Histone H3, Lysine 9-Specific Methyltransferase that Contributes to HP1-Mediated
Silencing of Euchromatic Genes by KRAB Zinc-Finger Proteins, 16 Genes & Dev. 919 (2002); Hengbin
Wang et al., Purification and Functional Characterization of a Histone H3-Lysine 4-Specific
Methyltransferase, 8 Molecular Cell 1027 (2001); Liu Yang et al., Molecular Cloning of ESET, a
Novel Histone H3-Specific Methyltransferase that Interacts with ERG Transcription Factor,
21 Oncogene 148 (2002). Researchers have also described a number of transcription co-activators that
have characteristic histone acetyltransferase activity and histone deacetylases, which contribute to
histone modification. See generally En Li, Chromatin Modification and Epigenetic Reprogramming in
Mammalian Development, 3 Nature Rev. Genetics 662 (2002). As a result, histone modifications can
turn genes “on” or “off,” depending on which modification has been made. Alterations to patterns of
histone modification can have a number of consequences, such as developmental dysregulation and
diseases. Research is continuing to explore how normal and altered histone modifications can control
gene expression, as well as how such modifications might be involved in regulating additional
epigenetic processes and disease states. See generally Vincenzo Calvanese et al., Cancer Genes
Hypermethylated in Human Embryonic Stem Cells, PLoS One, Sept. 2008, at 1.
60. Stella M. Reamon-Buettner et al., The Next Innovation Cycle in Toxicogenomics: Environmental
Epigenetics, 659 Mutation Res. 158, 159 (2008).
61. Knopik, supra note 24, at 1377–78.
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expression, may have utility not only as diagnostic biomarkers capable of
assessing levels of exposure to prenatal toxicants or predicting increased
risk for behavioral deficits, diseases, or disease progression, but also as
potential therapeutic targets.
C. Harmful Prenatal Exposures: Maternal Smoking During
Pregnancy and Associated Fetal Outcomes
During prenatal development, the fetus is especially sensitive to
harmful effects of a variety of exposures. The placenta, commissioned
with the role of aiding the fetus during this critical time period, plays a
crucial role in supporting the normal growth and development of the
fetus. The placenta provides the fetus with nutrients, assists in waste
removal, and exhibits a degree of metabolic activity that protects the
fetus from both maternal immune rejection and from other
62
environmental insults. As a center for metabolic activity, the placenta
63
produces and secretes hormones that support each stage of pregnancy.
The placenta is also responsible for the reactions that ultimately protect
64
the fetus from exposure to environmental toxicants. A number of drugs
65
66
67
and toxicants—including nicotine, alcohol, and benzo(a)pyrene —
have been found to affect placental gene expression, thereby altering the
ability of the placenta to ensure proper fetal growth and development.
Maternal cigarette smoking during pregnancy is associated with
increased risk of a number of pregnancy complications such as
68
69
70
spontaneous abortion, preterm delivery, and reduced birth weight.
Additional studies have shown that maternal cigarette smoking during
71
72
pregnancy is associated with respiratory disease, asthma and allergies,

62. Matthew A. Maccani et al., Maternal Cigarette Smoking During Pregnancy Is Associated with
Downregulation of miR-16, miR-21, and miR-146a in the Placenta, 5 Epigenetics 583, 583 (2010).
63. Maccani & Marsit, supra note 50, at 79.
64. Id.
65. Donna S. Lambers & Kenneth E. Clark, The Maternal and Fetal Physiologic Effects of
Nicotine, 20 Seminars Perinatology 115, 119–21 (1996).
66. See generally John O. Beattie, Transplacental Alcohol Intoxication, 21 Alcohol & Alcoholism
163 (1986).
67. See generally H.J. Guyda et al., Benzo(a)pyrene Inhibits Epidermal Growth Factor Binding and
Receptor Autophosphorylation in Human Placental Cell Cultures, 37 Molecular Pharmacology 137, (1990).
68. Anne Castles et al., Effects of Smoking During Pregnancy: Five Meta-Analyses, 16 Am. J.
Preventive Med. 208, 211(1999).
69. Id. at 212.
70. Matthew A. Maccani et al., miR-16 and miR-21 Expression in the Placenta Is Associated with
Fetal Growth, PLoS One, June 2011, at 1, 5.
71. Derek G. Cook & David P. Strachan, Summary of Effects of Parental Smoking on the
Respiratory Health of Children and Implications for Research, 54 Thorax 357, 357 (1999).
72. See Susan L. Prescott & Vicki Clifton, Asthma and Pregnancy: Emerging Evidence of Epigenetic
Interactions In Utero, 9 Current Opinion in Allergy & Clinincal Immunology 417, 417 (2009).

Smith_64-HLJ-1619 (Do Not Delete)

August 2013]

MATERNAL SMOKING DURING PREGNANCY

9/25/2013 12:24 PM

1633

73

and cancer. There are thousands of chemicals in cigarettes, including
nicotine, benzo(a)pyrene and carbon monoxide; more than forty of these
74
chemicals are known carcinogens. Previous work has shown that
nicotine can cross the placenta easily and can cause fetal concentrations
75
that are fifteen percent higher than maternal concentrations. Taken
collectively, the vast body of literature describing the harmful effects of
smoking during pregnancy suggests that maternal smoking remains a
potentially dangerous common exposure that can have major
ramifications not only on the normal growth and development of the
76
fetus but also on fetal programming.
Although several studies have described a decrease in the overall
prevalence of smoking in women in the past two decades, studies have also
shown that the prevalence of smoking in young pregnant women under
twenty years of age has increased to prevalence rates of thirty to forty
77
percent. Other studies have found that twelve to fifteen percent of all
78
women of childbearing age smoke while pregnant. In addition to the
effects of primary smoke exposure (maternal smoking during pregnancy),
it is necessary to consider the effects of secondhand smoke exposure on
the developing fetus. Pregnant women and their fetuses may be exposed to
secondhand smoke in homes, vehicles, the workplace, or public areas.
Studies suggest that more than 126 million nonsmoking adults are exposed
to secondhand smoke and that almost sixty percent of children ages three
79
to eleven are exposed to secondhand smoke. Collectively, cigarette
smoke remains a common and hazardous exposure, especially at sensitive
periods of development where exposure can have potentially serious, longterm effects on health.
In light of the plethora of scientific data suggesting negative
consequences associated with smoking during pregnancy, pregnant women
80
are cautioned against smoking while pregnant. However, despite the

73. S. P. Doherty et al., Early Life Insult From Cigarette Smoke May Be Predictive of Chronic
Diseases Later in Life, 14 Biomarkers 97, 99–100 (2009).
74. Anja Thielen et al., Tobacco Smoke: Unraveling a Controversial Subject, 60 Experimental &
Toxicologic Pathology 141, 147 (2008).
75. Lambers & Clark, supra note 65, at 116.
76. Maccani, supra note 62, at 583.
77. Knopik, supra note 24, at 1378. See generally Niina Jaakkola et al., Smoking During
Pregnancy in Finland: Determinants and Trends, 1987–1997, 91 Am. J. Pub. Health 284 (2001); U.S.
Dep’t Health & Human Servs., The Health Consequences of Involuntary Exposure to Tobacco
Smoke: A Report of the Surgeon General (2006).
78. Sven Cnattingius, The Epidemiology of Smoking During Pregnancy: Smoking Prevalence,
Maternal Characteristics, and Pregnancy Outcomes, 6 Nicotine & Tobacco Res. 125, 127 (2004). See
generally Renee D. Goodwin et al., Mental Disorders and Nicotine Dependence Among Pregnant
Women in the United States, 109 Obstetrics & Gynecology 875 (2007).
79. Knopik, supra note 24, at 1378. See generally U.S. Dep’t Health & Human Servs., supra note 77.
80. Knopik, supra note 24, at 1378. See generally Alison K. Shea & Meir Steiner, Cigarette Smoking
During Pregnancy, 10 Nicotine & Tobacco Res. 267 (2008). See generally Marie D. Cornelius & Nancy L.
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numerous research articles suggesting undesirable outcomes in children
exposed to prenatal smoke exposure and warnings encouraging women to
stop smoking while pregnant, a large percentage of women continue to
smoke during pregnancy or are exposed to the dangers of secondhand
smoke during pregnancy. Such figures, as well as the expenditure for
smoking-associated health problems in mothers, fetuses, and children,
beg for public health policy initiatives to more effectively communicate
the potential dangers of smoking during pregnancy, as well as to better
prevent the potentially harmful exposure to cigarette smoke altogether.
Considerations for such public health campaigns, such as evidence-based
policies for reducing maternal and paternal cigarette smoking during
pregnancy through taxation of cigarettes, increasing public awareness,
and smoking cessation interventions, are described later in this Article.
D. Maternal Smoking During Pregnancy: Epigenetics as a
Potential Link to Future Outcomes?
A number of studies have investigated links between maternal
smoking during pregnancy and aberrant epigenetic regulation of gene
expression, with such dysregulation potentially associated with
consequences for the fetus throughout the life course. Research by our
group and others has characterized epigenetic alterations in target tissues
associated with maternal cigarette smoking during pregnancy.
1. Maternal Smoking During Pregnancy and DNA Methylation
Studies of the human placenta have revealed associations between
maternal cigarette smoking during pregnancy and DNA methylation in a
gene specific and even global fashion. A group of researchers led by
Melissa Suter from Baylor College of Medicine observed that maternal
tobacco use is associated with aberrant placental epigenome-wide DNA
81
methylation and gene expression. In a separate study, Suter and her
colleagues described data suggesting that maternal tobacco smoking may
modify placental cytochrome P450, family 1, subfamily A, polypeptide 1
(“CYP1A1”) expression by altering methylation at CpG sites proximal
82
to the 50-xenobiotic response element transcription factor binding site.
CYP1A1 is involved in the metabolism of carcinogenic compounds such
as polycyclic aromatic hydrocarbons, which are present in cigarette
smoke. This study found that the placentas of babies born to mothers

Day, Developmental Consequences of Prenatal Tobacco Exposure, 22 Current Opinions in Neurology
121 (2009).
81. See generally Melissa Suter et al., Maternal Tobacco Use Modestly Alters Correlated
Epigenome-Wide Placental DNA Methylation and Gene Expression, 6 Epigenetics 1284 (2011).
82. See generally Melissa Suter et al. In Utero Tobacco Exposure Epigenetically Modifies
Placental CYP1A1 Expression, 59 Metabolism 1481 (2010).
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who smoked during pregnancy had significantly lower methylation at
83
these sites than babies born to nonsmoking mothers. This relative
decrease in methylation was also significantly correlated with increased
placental CYP1A1 expression, a finding that may have substantial
implications for future behavior.
Charlotte Wilhelm-Benartzi and colleagues showed that differential
methylation of repetitive elements (stretches of DNA exhibiting a large
number of repeated bases) in the placenta is associated with birth weight
84
percentile and maternal smoking during pregnancy. Specifically, they
found that mean methylation levels of the repetitive element AluYb8
85
significantly differed by maternal tobacco use during pregnancy.
Overall, these reports suggest that cigarette smoke may elicit some of its
downstream consequences on placental DNA methylation in both a
global and site-specific fashion.
Associations between maternal smoking during pregnancy and
DNA methylation have also been assessed using blood and specific cell
86
types isolated from blood. Y. Ba and colleagues used both maternal
blood and umbilical cord blood to measure specific gene promoter
methylation in insulin-like growth factor 2 (“IGF2”) , which plays a growth
87
factor role in the fetus. These results suggested that IGF2 promoter
methylation in the mother’s blood was associated with secondhand smoke
exposure, as well as other covariates including vitamin B12 maternal blood
88
serum levels and maternal weight gain during pregnancy. Mary Beth
Terry and colleagues investigated leukocyte (white blood cell) DNA
89
methylation profiles in a multiethnic birth cohort from New York City.
Multivariable models suggested that overall levels of DNA methylation
were significantly associated with maternal smoking during pregnancy
90
and with other covariates. Although such studies warrant replication in
a larger cohort, thereby increasing their applicability and enhancing the
ability to control for potential confounders, these studies of blood and
blood-derived cells collectively provide preliminary data important for
impelling future research into the utilization of DNA methylation

83. Id.
84. See generally Charlotte S. Wilhelm-Benartzi et al., In Utero Exposures, Infant Growth, and
DNA Methylation of Repetitive Elements and Developmentally Related Genes in Human Placenta,
120 Envtl. Health Persp. 296 (2012).
85. Id.
86. See generally Knopik, supra note 24.
87. See generally Y. Ba et al., Relationship of Folate, Vitamin B12 and Methylation of Insulin-Like
Growth Factor-II in Maternal and Cord Blood, 65 Eur. J. Clinical Nutrition 480 (2011).
88. Id.
89. See generally Mary Beth Terry et al., Genomic DNA Methylation Among Women in a Multiethnic
New York City Birth Cohort, 17 Cancer Epidemiology, Biomarkers, & Prevention 2306 (2008).
90. Id.
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patterns in cord blood or maternal blood as biomarkers of prenatal
exposures like smoking.
Other researchers have also worked to characterize associations
between maternal smoking during pregnancy and DNA methylation
profiles linked to brain and neurodevelopmental outcomes. Maria
Toledo-Rodriguez and colleagues investigated associations of maternal
cigarette smoking during pregnancy and promoter methylation of brainderived neurotrophic factor (“BDNF”) in blood samples from
91
adolescents whose mothers had smoked during pregnancy. BDNF—
which previous studies have shown is important for long-term memory—
acts on certain neurons of the central nervous system and the peripheral
nervous system, aids in supporting the survival of existing neurons, and
92
encourages the growth and differentiation of new neurons and synapses.
Toledo-Rodriguez and colleagues found that exposure to maternal
cigarette smoking in utero is associated with a greater level of DNA
methylation in the BDNF exon 6 in adolescents whose mothers smoked
during pregnancy, suggesting that in utero cigarette smoke exposure may
93
have long-term consequences still measurable into adolescence. Such
findings are especially intriguing in light of results suggesting that
methylation of BDNF may have future utility as a diagnostic blood
94
biomarker for depression.
Future work will continue to explore DNA methylation as a link
between maternal cigarette smoking during pregnancy and future health
outcomes. Such work will be necessary to further understand this link and
to develop potentially powerful diagnostic biomarkers of both exposure
and risk for future cigarette smoke exposure-associated disease.
2. Maternal Smoking During Pregnancy and miRNA
The body of literature characterizing associations between maternal
cigarette smoking during pregnancy and miRNA is limited compared to
the literature exploring associations with DNA methylation. Previous
work by Maccani and colleagues used a candidate miRNA approach to
measure changes in four human placental miRNA associated with
maternal cigarette smoking during pregnancy, finding that maternal
cigarette smoking during pregnancy was associated with decreased levels

91. Maria Toledo-Rodriguez et al., Maternal Smoking During Pregnancy Is Associated with
Epigenetic Modifications of the Brain-Derived Neurotrophic Factor-6 Exon in Adolescent Offspring,
153B Am. J. Med. Genetics pt. B 1350, 1350–54 (2010).
92. See generally Eric J. Huang & Louis F. Reichardt, Neurotrophins: Roles in Neuronal
Development and Function, 24 Ann. Rev. Neuroscience 677 (2001).
93. Toledo-Rodriguez et al., supra note 91, at 1352.
94. See generally Manabu Fuchikami et al., DNA Methylation Profiles of the Brain-Derived
Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression, PLoS One,
Aug. 2011, at 1.
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95

of miR-16, miR-21, and miR-146a in the placenta. They expanded their
work to further explore which of the thousands of chemicals in cigarettes
might be altering miRNA expression in placental cells, finding
specifically that miR-146a was decreased in placental cells treated with
nicotine and benzo(a)pyrene—two chemicals previously suggested to
96
have negative consequences on the fetus. As has been previously
97
reviewed, these observations were limited by sample size (here, 25), as
well as lack of extensive data on daily cigarette smoke usage and
98
exposure to other environmental toxicants. Nonetheless, this analysis
provides an important first investigation into associations between
maternal cigarette smoking during pregnancy and altered placental
miRNA expression. Future work investigating these associations in a
larger sample set with more extensive exposure information will be key
to further understand the impact of these associations and the
consequences for the fetus throughout life.
3. Maternal Smoking During Pregnancy and Histone Modifications
Histone modifications have also been investigated for associations
with maternal smoking during pregnancy. Virender Rehan and
colleagues injected pregnant rats with nicotine and showed that the pups
99
of these nicotine-exposed mothers developed asthma. Similarly, when
these pups were allowed to mature and breed, their resulting pups also
developed asthma, suggesting that the effects of nicotine exposure may
be transmitted across several generations even without direct exposure
100
of an individual to nicotine. The team found that one form of nicotineinduced acetylation of histone H3 could be blocked by a molecule known
to protect lungs from asthma, suggesting that nicotine-induced
acetylation of histone H3 might lead to asthma in both pups directly
exposed to prenatal nicotine and future generations of pups as a result of
101
the prenatal exposure of the pups’ sex cells to nicotine. Future
investigations will be key in order to further elucidate this relationship,
especially to determine how exposure to cigarette smoke might continue
to have negative consequences for future generations.

95. Maccani et al., supra note 62, at 583.
96. Id.
97. See generally Maccani & Marsit, supra note 57; Maccani & Knopik, supra note 56.
98. Maccani et al., supra note 62, at 583.
99. See generally Virender K. Rehan et al., Perinatal Nicotine Exposure Induces Asthma in Second
Generation Offspring, 10 BMC Med. 129 (2012); Grandma’s Curse: Some of the Effects of Smoking
May Be Passed From Grandmother to Grandchild, The Economist, Nov. 3, 2012, at 82.
100. Id.
101. Id.
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E. Expanding Prenatal Cigarette Smoke-Altered Epigenetics to
Postnatal Outcomes
As previously noted, researchers have yet to fully explore epigenetic
mechanisms which may underlie psychological disorders associated with
102
maternal cigarette smoking during pregnancy. One model that might
be further tested is that of “behavioral teratogenicity”—namely how fetal
brain exposure to nicotine and the pathological activation of acetylcholine
nicotinic receptors during early stages of brain development might lead to
103
downstream neurobehavioral consequences. Given that there is a high
degree of comorbidity between nicotine dependence and neuropsychiatric
104
conditions, researchers have struggled to determine how influential
exposure to cigarette smoke is on modulating risk for developing
psychological disorders. Epigenetic mechanisms are one such pathway by
which cigarette smoke could elicit harmful downstream effects on
neurobehavior.

III. Ethical, Policy, and Legal Considerations
A. Legal Effects of Prenatal Cigarette Smoke Exposure
Findings such as how the harmful effects of cigarette smoke
exposure might be transmitted during prenatal development and across
generations by epigenetic mechanisms introduce quite a number of
ethical, policy, and legal questions. Prenatal exposure to cigarette smoke
and grandmaternal transmission of the harmful effects of cigarette smoke
(and many other toxicants) may lead to a larger discussion on negligence,
criminal responsibility, and statutes of limitations.
To some readers, the notion of being held criminally responsible for
using substances during pregnancy may seem hypothetical and speculative.
However, at least thirty-four states’ legal statutes that were originally
intended to protect children after birth from the dangers associated with
methamphetamine labs and the trade and use of illicit drugs have been
extended to protect the health of the fetus and prosecute mothers who use
105
substances during pregnancy. In a lengthy expose in the New York Times
entitled “The Criminalization of Bad Mothers,” Ada Calhoun describes
how states have applied child abuse statutes to effectively punish mothers
who test positive for methamphetamines and other harmful substances
102. See generally Knopik, supra note 24.
103. See generally Rodrigo Paz et al., Behavioral Teratogenicity Induced by Nonforced Maternal
Nicotine Consumption, 32 Neuropsychopharmacology 693 (2007).
104. See generally Barbara Maughan et al., Prenatal Smoking and Early Childhood Conduct
Problems: Testing Genetic and Environmental Explanations of the Association, 61 Archives Gen.
Psychiatry 836 (2004).
105. See generally Jean Reith Schroedel et al., Women’s Rights and Fetal Personhood in Criminal
Law, 7 Duke J. Gender L. & Pol’y 89, 102 (2000).
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while pregnant or during the delivery of their child. Punishments range
from fines to, in the most egregious cases or in the case of repeated
107
offense, imprisonment.
Proponents of such practices argue that the punishments act as
deterrents to such behavior, which has been shown in previous analyses
to be associated with an increase in a child’s postnatal complications and
108
future neurobehavioral issues. Supporters of these practices also argue
that they have enacted such legislation to protect vulnerable members of
society: children. Opponents of these practices cite studies that report
that rates of mothers seeking prenatal care in states which have enacted
109
such harsh legislation are decreasing. Opponents argue that from a
public health perspective, these findings suggest that such legal practices
may do more harm than good for children in the long run. Furthermore,
opponents stress that although substantial scientific evidence exists
describing associations between prenatal drug exposures and postnatal
outcomes, the vast majority of these findings are epidemiological in
nature and such studies were not designed to test the causality of
whether a drug exposure actually causes a downstream neurobehavioral
outcome. Regardless of position on the issue, a level of caution, a
consideration for legal precedent, the intent of the “bad actor,” and a
considerable knowledge of the body of scientific literature is necessary
when considering legal practices that effectively criminalize negative
maternal and paternal behavior during pregnancy.
Maternal substance use during pregnancy is also often viewed within
the larger fetal rights debate, which includes the legal definition of
110
personhood and laws related to abortion and fetal homicide. For
example, given that a viable fetus is considered a “child” in the state of
South Carolina, the Supreme Court of South Carolina ruled that
maternal substance use during pregnancy could be prosecuted as child
111
abuse. In this domain, the maternal-fetal rights conflict stems from
interventions aiming to improve fetal health trajectories by altering
maternal behavior. Although these types of interventions aim to limit
adverse prenatal environmental exposures (which may improve fetal
health trajectories), opponents of such interventions argue that they also

106. Ada Calhoun, The Criminalization of Bad Mothers, N.Y. Times, Apr. 25, 2012, at MM30.
107. Id.
108. Cynthia Dailard & Elizabeth Nash, State Responses to Substance Abuse Among Pregnant
Women, Guttmacher Rep. Pub. Pol’y, Dec. 2000, at 1, 5.
109. See, e.g., Marilyn L. Poland et al., Punishing Pregnant Drug Users: Enhancing the Flight From
Care, 31 Drug & Alcohol Dependence 199, 202 (1993); U.S. Gen. Accounting Office, GAO/HRD90-198, Drug-Exposed Infants: A Generation at Risk, at 9–10 (1990).
110. See generally Schroedel, supra note 105.
111. Whitner v. State, 492 S.E.2d 777, 778 (S.C. 1997).
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have the potential to infringe on women’s autonomy and civil liberties.
The maternal-fetal rights conflict is often viewed as a zero sum game,
meaning that any increase in fetal rights results in a decrease in maternal
rights, and vice versa. In practice, however, interventions and policies may
increase both maternal and fetal rights by increasing maternal autonomy
and fetal health. Therefore, viewing maternal-fetal rights and health as
complementary, rather than contrary, may allow for interventions and
113
policies that are most effective in improving maternal-fetal health.
In women, substance abuse disorder onset typically occurs prior to
114
conception. Women who are substance dependent and become pregnant
represent important candidates for substance use intervention, education,
115
or possibly treatment. One’s belief about what causes someone to use
substances or smoke cigarettes may have an important impact on one’s
perceptions on the culpability and malleability of maternal smoking during
pregnancy. Converging lines of evidence demonstrate that smoking
initiation and nicotine dependence may be the result of both genetic and
116
environmental influences; however, over one-third of individuals believe
117
that genetics do not influence smoking behavior and hold overly
simplified views of how substance abuse develops. Furthermore, other
types of human behavior and traits are commonly viewed as having either
118
genetic or environmental influences, a view which contradicts wellestablished behavioral genetic findings.
Oversimplified beliefs that contradict well-established scientific
findings about what may influence deviant behavior, such as substance
abuse, may have important legal implications. For example, if an
individual is led to believe that deviant behavior has predominantly
119
genetic origins they will be more likely to believe it is serious,
120
determined, and immutable. On the contrary, if deviant behavior is
believed to result from non-genetic causes, the behavior is seen as more

112. Deborah Hornstra, A Realistic Approach to Maternal-Fetal Conflict, 28 Hastings Ctr. Rep. 7,
10 (1998).
113. Schroedel, supra note 105, at 117.
114. Am. Soc’y Addiction Med., Public Policy Statement on Women, Alcohol and Other Drugs, and
Pregnancy, 1 (July 11, 2011), http://www.asam.org/docs/publicy-policy-statements/1womenandpregnancy_711.pdf.
115. Id.
116. See generally Hermine H. Maes et al., A Twin Study of Genetic and Environmental Influences
on Tobacco Initiation, Regular Tobacco Use and Nicotine Dependence, 34 Psychol. Med. 1251 (2004).
117. Alison J. Wright et al., Is Attributing Smoking to Genetic Causes Associated with a Reduced
Probability of Quit Attempt Success? A Cohort Study, 102 Addiction 1657, 1659 (2007).
118. Toby E. Jayaratne et al., The Perennial Debate: Nature, Nurture, or Choice? Black and White
Americans’ Explanations for Individual Differences, 13 Rev. Gen. Psychol. 24, 27 (2009).
119. Jo C. Phelan, Geneticization of Deviant Behavior and Consequences for Stigma: The Case of
Mental Illness, 46 J. Health & Soc. Behav. 307, 317 (2005).
120. Ilan Dar-Nimrod & Steven J. Heine, Genetic Essentialism: On the Deceptive Determinism of
DNA, 137 Psychol. Bull. 800, 802 (2011).
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voluntary, blameworthy, and is elected to receive more severe
121
punishments. Together, these findings suggest that people’s causal
attributions of deviant behavior often lack an empirical basis and alter
beliefs about personal responsibility and appropriate punishment. These
biases highlight the importance of understanding that the majority of
health and behavior outcomes are the result of genetic and environmental
factors, which are both statistically and functionally related. For example,
genetic factors may predispose individuals to be exposed to particular
122
and environmental exposures influence biological
environments
vulnerability through a number of mechanisms.
In moving forward with translating scientific findings into effective
public health policy, a special focus should be given to prevent harmful
prenatal exposures, where possible, in the first place, thereby promoting
fetal health and protecting future children; at the same time, maternal
and paternal rights need to be acknowledged and protected.
B. Interventions to Reduce Cigarette Smoke Exposure in Early
Development
A variety of interventions are aimed at increasing rates of smoking
cessation and reducing rates of smoking initiation. The Centers for
Disease Control and Prevention (“CDC”) recommends a multi-pronged
approach, including state and community-level interventions, health
communication, and cessation programs, as well as mechanisms to both
123
manage and evaluate such interventions. The following discussion is
not meant to endorse a specific approach to intervention, but rather to
highlight the relative costs and benefits of approaches that reduce rates
of smoking in both the general population and in pregnant women.
1. Legislative Interventions
124

Tobacco control spending, tobacco counter-marketing, cigarette
excise taxes, and restricting smoking in public places all represent cost125
effective policies that influence smoke exposure in the population. The
126
CDC program suggestions indicated that higher level and longer
periods of tobacco control spending were related to a greater reduction
in smoking prevalence. Every dollar spent on tobacco control spending

121. Phelan, supra note 119, at 316–17.
122. Kendler & Baker, supra note 41, at 620–21.
123. Ctrs. for Disease Control & Prevention, Best Practices for Comprehensive Tobacco
Control Programs 7, 34 (2007).
124. Tobacco control spending refers to state and federal money that is used to support efforts to
prevent or reduce tobacco use.
125. Jennifer W. Kahende et al., A Review of Economic Evaluations of Tobacco Control
Programs, 6 Int’l J. Envtl. Res. & Pub. Health 51, 54–63 (2009).
126. Ctrs. for Disease Control & Prevention, supra note 123, at 9.
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has been estimated to be associated with a health care savings of
127
approximately five dollars. To the extent that fetal and child exposure to
smoking puts individuals at risk for later negative health and behavioral
outcomes, and that risk may be transmitted between generations, current
cost-effectiveness measures may underestimate the benefits of such
programs.
Adams and colleagues found that level of tobacco control spending
was associated with lower postpartum smoking in older mothers;
however, there was no relationship between tobacco control spending
128
level and reported prenatal smoking. One explanation for this is that
129
state spending does not reach CDC recommendations, while another
possibility may be that states are failing to most effectively channel funds
currently designated for tobacco control—for example, by investing in
programs that consistently underperform or are not effective in
improving tobacco control. The CDC estimates that states need to spend
between $9.23 and $18.02 per capita to implement an effective
130
comprehensive tobacco control program. Currently, the majority of
131
states are spending far below such estimates. Despite record levels of
tobacco revenue from taxes and the 1998 Tobacco Master Settlement
132
Agreement, current tobacco control spending has decreased over the
past decade. Currently, less than two percent of tobacco related revenue
133
is spent on prevention and tobacco cessation programs, which is
134
associated with state revenues. However, in addition to state revenue,
state tobacco control spending is associated with the level of state
135
tobacco production and campaign contributions from tobacco lobbies.
These findings suggest that tobacco special interest groups may make it
more difficult for states to reach spending levels that are needed to

127. Julia A. Dilley et al., Program, Policy, and Price Interventions for Tobacco Control: Quantifying
the Return on Investment of a State Tobacco Control Program, 102 Am. J. Pub. Health 22, 24 (2012).
128. E. Kathleen Adams et al., Reducing Prenatal Smoking: The Role of State Policies, 43 Am. J.
Preventive Med. 34, 39 (2012).
129. Id.
130. Ctrs. for Disease Control & Prevention, supra note 123, at 15. According to the CDC, best
practices to reduce tobacco use were created from an “evidence-based analyses of scientific literature
and outcomes of comprehensive state tobacco control programs and interventions.” Id. at 14. For an
overview on how recommended funding levels for each state were determined, see id. at 111–12.
131. Campaign for Tobacco-Free Kids, Broken Promises to Our Children: The 1998 State
Tobacco Settlement 14 Years Later i (2012).
132. See, e.g., Cal. Health & Safety Code §§ 104555–58 (2000) (codifying California’s adoption of
the Master Settlement Agreement).
133. Sabrina Tavernise, States Cut Antismoking Outlays Despite Record Tobacco Revenue, N.Y.
Times, Dec. 6, 2012, at A.19.
134. Adam J. Hoffer & Adam Pellillo, The Political Economy of Tobacco Control Spending,
19 Applied Econ. Letters 1793, 1795 (2012).
135. Id. at 1796.
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implement the effective tobacco control programs described by the
136
CDC.
Tobacco counter-marketing and marketing restrictions also aim to
reduce smoking initiation and increase smoking cessation. In the United
States, current tobacco health warning labels have remained largely
137
unchanged since 1984 and are easily overlooked. Four different
cigarette health warnings in text are currently placed on the side of
United States cigarette packs. In contrast, more prominent pictorial and
text cigarette health warnings labels have been utilized in at least fortyfive countries. Investigative analyses suggest that these health warning
labels effectively increase thoughts about quitting and may decrease
138
smoking rates. In addition, pictorial cigarette health warnings have been
shown to increase intentions to quit across a variety of socio-demographic
139
and racial or ethnic groups. In 2009, The Family Smoking Prevention
and Tobacco Control Act introduced additional marketing restrictions on
tobacco products and granted the Food and Drug Administration
140
(“FDA”) the authority to regulate tobacco-related marketing. As a
result, the FDA mandated that nine new pictorial and text labels be
141
included on cigarette packages beginning September 2012. For example,
one label reads “WARNING: SMOKING DURING PREGNANCY
CAN HARM YOUR BABY” and is accompanied by a cartoon picture of
142
a baby in an incubator. The D.C. district court, however, found that the
FDA mandate violated the tobacco company’s First Amendment
143
rights. This decision was upheld by a divided court of appeals which
cited insufficient evidence that pictorial cigarette warning labels reduced
144
smoking rates. The future use of more graphic tobacco health warnings
in this country remains unclear and additional research into the influence
of graphic tobacco health warnings on rates of smoking initiation and
cessation is needed.

136. See generally Centers for Disease Control & Prevention, supra note 123.
137. Jennifer Cantrell et al., Impact of Tobacco-Related Health Warning Labels Across
Socioeconomic, Race and Ethnic Groups: Results from a Randomized Web-Based Experiment, PLoS
One, Jan. 2013, at 1, 1; Thomas N. Robinson & Joel D. Killen, Do Cigarette Warning Labels Reduce
Smoking? Paradoxical Effects Among Adolescents, 151 Archives Pediatrics & Adolescent Med. 267,
271–72 (1997).
138. David Hammond, Health Warning Messages on Tobacco Products: A Review, 20 Tobacco
Control 327, 332 (2011); David Hammond et al., Communicating Risk to Smokers: The Impact of
Health Warnings on Cigarette Packages, 32 Am. J. Preventive Med. 1, 5–6 (2007).
139. See generally Cantrell, supra note 137.
140. Pub. L. No. 111-31, 123 Stat. 1776, 1777 (2009) (codified as amended at 21 U.S.C. §§ 387–87u
(2009)).
141. Id. § 201(d).
142. Cigarette Health Warnings, Food & Drug Admin., http://www.fda.gov/downloads/
TobaccoProducts/Labeling/UCM259401.pdf (last visited July 30, 2013).
143. R.J. Reynolds Tobacco Co. v. FDA, 845 F. Supp. 2d 266, 277 (D.D.C. 2012).
144. R.J. Reynolds Tobacco Co. v. FDA, 696 F.3d 1205, 1222 (D.C. Cir. 2012).
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Research has shown that increases in cigarette excise taxes may
145
reduce the prevalence of smoking in the general population. In
addition, one group of researchers found that amongst pregnant women,
a one dollar increase in cigarette taxes was associated with a 4.8%
increase in the probability of smoking cessation by the third trimester, an
146
effect that remained largely intact four months after delivery.
Furthermore, the relationship between increased cigarette taxes and
increased smoking cessation did not depend on maternal education, level
147
of pre-pregnancy smoking, or parity. Parallels have been observed in
the context of raising minimum prices of alcohol, which could offer hope
for the potential effectiveness of such increased pricing on reducing
harms associated with dangerous substances of abuse. In British
Columbia, a 10% increase in the minimum price for the least expensive
alcoholic beverages led to a 3.4% decrease in consumption of alcoholic
148
149
beverages and a 31.7% decrease in alcohol attributable deaths.
Together, these findings suggest that increasing cigarette excise taxes
may help to reduce smoking rates and smoking-related morbidity and
mortality.
Smoking bans in public places (such as restaurants and bars)
represent another legislative intervention which may impact maternal
smoking during pregnancy in public places. In addition to the social
150
stigma associated with smoking in public during pregnancy, this type of
legislation may be another barrier to smoking in public during
pregnancy. Evidence suggests that smoking bans in public places are
generally associated with increased smoking cessation, as well as
151
decreased tobacco consumption and secondhand smoke exposure. In
addition, full smoking bans in private workplaces were associated with a
5% increase in the probability that an expecting mother would quit
152
smoking by the third trimester. Taken together, smoking bans in public
places may offer another effective means for reducing fetal exposure to

145. See generally F.J. Chaloupka et al., Effectiveness of Tax and Price Policies in Tobacco
Control, 20 Tobacco Control (2011).
146. Adams et al., supra note 128, at 37.
147. See generally T. Coleman et al., Pharmacological Interventions for Promoting Smoking
Cessation During Pregnancy, 9 Cochrane Database Systematic Revs. (2012).
148. Tim Stockwell et al., Does Minimum Pricing Reduce Alcohol Consumption? The Experience
of a Canadian Province. 107 Addiction 912, 916 (2012).
149. See generally Jinhui Zhao et al., The Relationship Between Minimum Alcohol Prices, Outlet
Densities and Alcohol Attributable Deaths in British Columbia, 2002–09, 108 Addiction 1059 (2013).
150. Leona Bull, et al., Social Attitudes Towards Smoking in Pregnancy in East Surrey: A Qualitative
Study of Smokers, Former Smokers and Non-Smokers, 13 J. Neonatal Nursing 100, 101 (2007).
151. See generally Joanne E. Callinan et al., Legislative Smoking Bans for Reducing Secondhand
Smoke Exposure, Smoking Prevalence and Tobacco Consumption (Review), Cochrane Database
Systematic Revs. (2010).
152. Adams et al., supra note 127, at 34–35.
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smoke in utero by reducing maternal rates of smoking and by reducing
the level of secondhand smoke exposure.
2.

Smoking Cessation Treatment

Smoking cessation programs have also been shown to increase rates
153
Proactive
of smoking cessation among smokers looking to quit.
interventions for smokers who are not ready to quit, however, are less
154
likely to be effective. Smoking cessation programs for pregnant women
also increase smoking cessation; however, across the most wellcontrolled studies (randomized clinical trials and biochemical validation
of smoking cessation), the mean smoking cessation rate is only four
155
percent. Although smoking cessation treatments are more effective in
increasing rates of smoking cessation compared to placebos, there is still
a need to enhance the effectiveness of such programs.
Smoking cessation programs may also include pharmacotherapy.
For example, nicotine replacement therapy (including patches or gum)
may be effective in increasing smoking cessation in the general
156
population, as both a supplement and an independent treatment. The
safety of nicotine replacement therapy in pregnant mothers, however, is
157
currently controversial. An initial report linked first trimester use of
158
nicotine replacement therapy with increased congenital malformations,
but a recent meta-analysis found that the relationship between nicotine
159
replacement therapy and perinatal outcomes is currently inconclusive.
Although other pharmacotherapies for smoking cessation exist (such as
buproprion and varenicline), the effectiveness and side effects of these
drugs have not been rigorously examined in pregnant mothers.
In order to further reduce smoking during pregnancy, it is also
important to consider that many psychosocial risk factors are associated
160
161
with maternal smoking during pregnancy including less education,

153. Jerry M. Suls et al., Efficacy of Smoking-Cessation Interventions for Young Adults: A MetaAnalysis, 42 Am. J. Preventative Med. 655, 660–61(2012).
154. Lisa Sanderson Cox et al., Predictors of Early Versus Late Smoking Abstinence Within a 24Month Disease Management Program, 13 Nicotine & Tobacco Res. 215, 218 (2011).
155. KB Filion et al., The Effect of Smoking Cessation Counselling in Pregnant Women: a Metaanalysis of Randomised Controlled Trials, 118 BJOG: Int’l J. Obstetrics & Gynaecology 1422, 1424 (2011).
156. See generally L.F. Stead & T. Lancaster, Combined Pharmacotherapy and Behavioural
Interventions for Smoking Cessation, The Cochrane Libr. (2012).
157. See generally Coleman et al., supra note 147.
158. See generally Maria M. Morales-Suárez-Varela et al., Smoking Habits, Nicotine Use, and
Congenital Malformations, 107 Obstetrics & Gynecology 51 (2006).
159. See generally Coleman et al.. supra note 147.
160. Valerie S. Knopik, Commentary: Smoking During Pregnancy—Genes and Environment
Weigh In, 39 Int’l J. Epidemiology 1203, 1203–04 (2010).
161. Brian M. D’Onofrio et al., A Quasi-Experimental Study of Maternal Smoking During
Pregnancy and Offspring Academic Achievement, 81 Child Dev. 80, 89 tbl.2 (2010).
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substance dependence and psychiatric comorbidity, having a substance
163
164
dependent partner, and having a history of criminal conviction. This
suggests that maternal smoking during pregnancy may be maintained, in
part, by other psychosocial factors and that maternal smoking during
165
pregnancy may be a way that mothers cope with such stressors.
Mothers who continue to smoke during pregnancy tend to smoke more
and experience more psychosocial stress than mothers who quit smoking
166
during pregnancy. Thus, to increase the effectiveness of interventions
aimed at reducing maternal smoking during pregnancy, it is important to
also target psychosocial stressors that may contribute to mothers
maintaining their smoking during pregnancy.

Conclusion
167
The growing application of the DOHaD hypothesis and inclusion of
epigenetic profiling in health and behavioral studies has great potential for
improving public health. Specifically, the DOHaD paradigm emphasizes
the importance of early environmental influences, especially prenatal and
intergenerational environmental effects, in influencing vulnerability for
later health outcomes. Additionally, epigenetic mechanisms provide
insight into how the environment may “get under the skin” to influence
gene expression and vulnerability for later health outcomes. DOHaD and
epigenetic research findings may have wide-ranging applications in legal
policy and practice. Such findings may easily be misunderstood or
misinterpreted, however, due to the complex relationships among
maternal smoking during pregnancy, epigenetic regulation, and later
health outcomes. Therefore, any application of these findings to legal
policy and practice requires great care, as well as a thorough
understanding of multiple scientific disciplines and legal precedents.
This Article provides an overview of scientific findings examining
the interrelationships between maternal smoking during pregnancy,
epigenetic regulation, and health related outcomes. Maternal smoking

162. Arpana Agrawal et al., Correlates of Cigarette Smoking During Pregnancy and its Genetic and
Environmental Overlap with Nicotine Dependence, 10 Nicotine & Tobacco Res. 567, 573–76 (2008).
163. Valerie S. Knopik et al., Contributions of Parental Alcoholism, Prenatal Substance Exposure, and
Genetic Transmission to Child ADHD Risk: A Female Twin Study, 35 Psychol. Med. 625, 630 (2005).
164. Brian M. D’Onofrio et al., Familial Confounding of the Association Between Maternal
Smoking During Pregnancy and Offspring Criminality: A Population-Based Study in Sweden,
67 Archives Gen. Psychiatry 529, 532–33 (2010).
165. William D. Lopez et al., Abuse-Related Post-Traumatic Stress, Coping, and Tobacco Use in
Pregnancy, 40 J. Obstetric, Gynecologic & Neonatal Nursing 422, 425 (2011).
166. See generally Kate E. Pickett et al., The Psychosocial Context of Pregnancy Smoking and
Quitting in the Millennium Cohort Study, 63 J. Epidemiology & Community Health 474 (2009).
167. Peter Gluckman & Mark A. Hanson, Living with the Past: Evolution, Development, and
Patterns of Disease, 305 Science 1733, 1733 (2004).
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during pregnancy and other forms of pre- and postnatal smoke exposure
168
continue to be associated with negative health consequences.
Findings linking maternal smoking during pregnancy with aberrant
patterns of epigenetic regulation provide insight into how prenatal
169
smoke exposure may alter vulnerability for later health outcomes.
Furthermore, negative health sequelae associated with cigarette smoke
170
exposure may be transmitted from one generation to the next,
171
potentially through intergenerational epigenetic effects. These findings
may provide insight into the nature of the relationship between maternal
smoking during pregnancy and subsequent offspring health outcomes.
Due to the study design limitations of several of the human studies
discussed, it should be noted that these studies were unable to test for a
causal relationship between maternal smoking during pregnancy and
later health outcomes; therefore, special care should be taken in
interpreting the results of such epidemiological studies. Additional
experimental studies investigating the interrelationships between
maternal smoking during pregnancy, epigenetic regulation, and offspring
health outcomes may be needed to test for a causal relationship between
maternal smoking during pregnancy and later health outcomes.
Bearing these limitations in mind, findings linking maternal smoking
during pregnancy to aberrant epigenetic regulation or later offspring
health outcomes pose important ethical, legal, and policy questions. A
conflict in maternal-fetal rights may arise when maternal substance use
leads to a decline in the fetus’s health trajectory or when attempts to
promote fetal health trajectories infringe on an expecting mother’s
172
autonomy. To promote fetal health, a variety of states have criminally
173
prosecuted mothers who abused substances during pregnancy.
However, this practice may have paradoxical effects on fetal health
because mothers who use substances during pregnancy may be less likely
to seek prenatal care if they may suffer the consequences of prosecution
as a result of the criminalization of maternal substance use during
174
pregnancy. Although maternal and fetal rights are often viewed in
opposition to one another—as in the case of abortion—this does not
175
necessarily hold true for maternal substance use during pregnancy.
Viewing maternal-fetal rights and health as complementary may allow

168.
169.
170.
171.
172.
173.
174.
175.

See generally Knopik, supra note 24.
Id. at 1379–81.
Misra et al., supra note 8, at 291–92.
Rehan et al., supra note 99, at 139.
See generally Hornstra, supra note 112.
Calhoun, supra note 106.
Poland et al., supra note 109, at 201–02.
See generally Schroedel et al., supra note 105.

Smith_64-HLJ-1619 (Do Not Delete)

1648

HASTINGS LAW JOURNAL

9/25/2013 12:24 PM

[Vol. 64:1619

for more effective legal policies and interventions aimed at improving
fetal health trajectories.
There are a variety of effective interventions aimed at reducing
levels of maternal smoking during pregnancy that do not infringe on
maternal autonomy. The CDC recommends a multi-level approach for
176
Tobacco control
reducing the public health impact of smoking.
spending, tobacco excise taxes, and smoking bans are all associated with
decreased smoking in expecting mothers and mothers who recently gave
177
birth. Specifically, increasing the price of cigarettes by one dollar led to
a four to five percent increase in smoking cessation among expecting
178
mothers. These initiatives have been shown to be effective in increasing
smoking cessation in a small but meaningful percentage of women who
smoke during pregnancy. Smoking cessation programs targeted
specifically at women of child bearing age or those who are expecting
may further reduce rates of prenatal smoke exposures.
Smoking cessation therapy is effective in the general population of
179
smokers who are motivated to quit and leads to an approximately 4%
180
increase in smoking cessation rates among pregnant women. Smoking
cessation programs targeting smokers who are not ready to quit are less
181
likely to be effective. Given that maternal substance use during
182
pregnancy is associated with a host of additional psychosocial stressors,
interventions aimed at reducing smoking during pregnancy may require a
more comprehensive approach, which addresses factors that serve to
maintain maternal substance use during pregnancy and beyond.
In summary, there is a substantial body of evidence linking maternal
smoking during pregnancy with a variety of negative offspring health
outcomes. Epigenetic mechanisms may: (1) help to explain how prenatal
smoke exposure influences biological vulnerability for later health
outcomes, and (2) be involved in the transmission of the negative effects
of prenatal smoke exposure from one generation to the next. Legal
policy and practice will continue to shape the impact that current and
future epigenetic findings linking prenatal exposures to harmful
postnatal outcomes will have on both fetal and maternal health.
Scientifically-informed policy and legal practice will be important as
policy makers strive to reduce the harms associated with prenatal smoke
exposure and strike the appropriate balance in the maternal and fetal
rights debate.

176.
177.
178.
179.
180.
181.
182.

Ctrs. for Disease Control & Prevention, supra note 123, at 7, 34.
Adams et al., supra 128, at 37.
Id.
Suls et al., supra note 153, at 661.
Filion et al., supra note 155, at 1424.
Cox et al., supra note 154, at 218.
Knopik supra note 160, at 1203–04.

